
Medtronic PLC
MDT92.330USD
+0.819+0.89%
Cierre 03/13, 16:00(ET)Cotizaciones retrasadas 15 min
121.07BCap. mercado
28.42P/E TTM
Información de Medtronic PLC Compañía
Información de la empresa
Código de la empresaMDT
Nombre de la empresaMedtronic PLC
Fecha de salida a bolsaNov 21, 1977
Fundada en2014
Director ejecutivoMr. Geoffrey S. (Geoff) Martha
Número de empleados95000
Tipo de títulosOrdinary Share
Fin del año fiscalNov 21
DirecciónBuilding Two Parkmore Business Park West
CiudadDUBLIN
Bolsa de valoresNYSE Consolidated
PaísIreland; Republic of
Código postalH91 4K49
Teléfono1135314381700
Sitio Webhttps://www.medtronic.com/
Código de la empresaMDT
Fecha de salida a bolsaNov 21, 1977
Fundada en2014
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.02M
+0.45%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President and President - Cardiovascular Portfolio
Executive Vice President and President - Cardiovascular Portfolio
543.90K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
486.64K
-0.61%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
111.10K
+90.72%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
61.50K
--
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.33K
-6.34%
Ms. Denise M. O'Leary
Ms. Denise M. O'Leary
Independent Director
Independent Director
48.74K
+0.66%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
46.08K
+2.02%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
Executive Vice President, President - Medical Surgical Portfolio and Surgical Operating Unit
39.00K
-1.45%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
38.29K
+0.19%
Ver más
Nombre
Nombre/Posición
Posición
Accionados
Cambio
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.02M
+0.45%
Mr. Sean M. Salmon
Mr. Sean M. Salmon
Executive Vice President and President - Cardiovascular Portfolio
Executive Vice President and President - Cardiovascular Portfolio
543.90K
-0.12%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President and President - Neuroscience Portfolio
Executive Vice President and President - Neuroscience Portfolio
486.64K
-0.61%
Mr. Gregory L. Smith
Mr. Gregory L. Smith
Executive Vice President - Global Operations and Supply Chain
Executive Vice President - Global Operations and Supply Chain
111.10K
+90.72%
Mr. Thierry Jean Louis Pieton
Mr. Thierry Jean Louis Pieton
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
61.50K
--
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.33K
-6.34%
Desglose de ingresos
Divisa: USDHora de actualización: mié., 5 de mar
Divisa: USDHora de actualización: mié., 5 de mar
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Surgical & Endoscopy
1.59B
19.24%
Cardiac Rhythm & Heart Failure
1.54B
18.63%
Cranial & Spinal Technologies
1.25B
15.07%
Structural Heart & Aortic
874.00M
10.54%
Specialty Therapies
732.00M
8.82%
Other
2.29B
27.67%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
4.23B
51.09%
Rest of World
4.02B
48.56%
Ireland
28.00M
0.33%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Surgical & Endoscopy
1.59B
19.24%
Cardiac Rhythm & Heart Failure
1.54B
18.63%
Cranial & Spinal Technologies
1.25B
15.07%
Structural Heart & Aortic
874.00M
10.54%
Specialty Therapies
732.00M
8.82%
Other
2.29B
27.67%
Accionista
Hora de actualización: mar., 11 de mar
Hora de actualización: mar., 11 de mar
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
9.63%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Global Advisors (US)
4.71%
Capital Research Global Investors
2.58%
Geode Capital Management, L.L.C.
2.10%
Other
75.64%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
9.63%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Global Advisors (US)
4.71%
Capital Research Global Investors
2.58%
Geode Capital Management, L.L.C.
2.10%
Other
75.64%
Tipo
Accionista
Proporción
Investment Advisor/Hedge Fund
39.32%
Investment Advisor
34.43%
Research Firm
3.91%
Pension Fund
2.44%
Hedge Fund
2.15%
Bank and Trust
2.10%
Sovereign Wealth Fund
1.22%
Insurance Company
0.39%
Individual Investor
0.24%
Other
13.75%
Participación institucional
Hora de actualización: jue., 20 de feb
Hora de actualización: jue., 20 de feb
Periodo de informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
3660
1.11B
86.96%
+1.10M
2024Q4
3768
1.11B
87.17%
+3.13M
2024Q3
3708
1.09B
85.63%
-24.54M
2024Q2
3725
1.10B
86.25%
-54.15M
2024Q1
3789
1.14B
85.95%
-7.86M
2023Q4
3780
1.13B
85.36%
-20.56M
2023Q3
3761
1.13B
85.37%
-14.93M
2023Q2
3764
1.13B
85.01%
-24.31M
2023Q1
3738
1.13B
85.40%
-14.70M
2022Q4
3689
1.12B
84.79%
-25.97M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
123.63M
9.63%
+776.43K
+0.63%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
68.04M
5.3%
+1.54M
+2.31%
Dec 31, 2024
State Street Global Advisors (US)
60.43M
4.71%
-293.90K
-0.48%
Dec 31, 2024
Capital Research Global Investors
33.20M
2.58%
+571.70K
+1.75%
Dec 31, 2024
Geode Capital Management, L.L.C.
27.05M
2.1%
+574.05K
+2.16%
Dec 31, 2024
JP Morgan Asset Management
24.33M
1.89%
+2.86M
+13.36%
Dec 31, 2024
MFS Investment Management
19.23M
1.49%
-3.63M
-15.91%
Dec 31, 2024
DWS Investment GmbH
14.65M
1.14%
+197.49K
+1.36%
Dec 31, 2024
Norges Bank Investment Management (NBIM)
14.56M
1.13%
-1.01M
-6.49%
Dec 31, 2024
BlackRock Financial Management, Inc.
13.22M
1.03%
+764.34K
+6.13%
Dec 31, 2024
Ver más
ETF relacionados
Hora de actualización: mié., 5 de mar
Hora de actualización: mié., 5 de mar
Nombre
Proporción
Polen Capital International Growth ETF
5.7%
NYLI Healthy Hearts ETF
5.23%
Absolute Select Value ETF
5.12%
iShares U.S. Medical Devices ETF
4.95%
Cullen Enhanced Equity Income ETF
3.85%
iShares Large Cap Value Active ETF
3.84%
USCF Dividend Income Fund
3.67%
American Century Focused Large Cap Value ETF
3.66%
Morgan Dempsey Large Cap Value ETF
3.25%
Madison Covered Call ETF
3.09%
Ver más
Polen Capital International Growth ETF
Proporción5.7%
NYLI Healthy Hearts ETF
Proporción5.23%
Absolute Select Value ETF
Proporción5.12%
iShares U.S. Medical Devices ETF
Proporción4.95%
Cullen Enhanced Equity Income ETF
Proporción3.85%
iShares Large Cap Value Active ETF
Proporción3.84%
USCF Dividend Income Fund
Proporción3.67%
American Century Focused Large Cap Value ETF
Proporción3.66%
Morgan Dempsey Large Cap Value ETF
Proporción3.25%
Madison Covered Call ETF
Proporción3.09%
Dividendos
Un total de
16.67B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Dec 05, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jan 10, 2025 going ex on Dec 27, 2024 with reinvestment option
Dec 27, 2024
Jan 10, 2025
Dec 27, 2024
Aug 16, 2024
MDT.NB Final Cash Dividend of gross USD 0.7 paid on Oct 11, 2024 going ex on Sep 27, 2024 with reinvestment option
Sep 27, 2024
Oct 11, 2024
Sep 27, 2024
May 23, 2024
MDT.NB Interim Cash Dividend of gross USD 0.7 paid on Jul 12, 2024 going ex on Jun 28, 2024 with reinvestment option
Jun 28, 2024
Jul 12, 2024
Jun 28, 2024
Mar 07, 2024
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Apr 12, 2024 going ex on Mar 21, 2024 with reinvestment option
Mar 22, 2024
Apr 12, 2024
Mar 21, 2024
Dec 07, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jan 12, 2024 going ex on Dec 19, 2023
Dec 20, 2023
Jan 12, 2024
Dec 19, 2023
Aug 17, 2023
MDT.NB Final Cash Dividend of gross USD 0.69 paid on Oct 13, 2023 going ex on Sep 21, 2023 with reinvestment option
Sep 22, 2023
Oct 13, 2023
Sep 21, 2023
May 25, 2023
MDT.NB Interim Cash Dividend of gross USD 0.69 paid on Jul 14, 2023 going ex on Jun 22, 2023 with reinvestment option
Jun 23, 2023
Jul 14, 2023
Jun 22, 2023
Mar 02, 2023
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Apr 14, 2023 going ex on Mar 23, 2023
Mar 24, 2023
Apr 14, 2023
Mar 23, 2023
Dec 08, 2022
MDT.NB Interim Cash Dividend of gross USD 0.68 paid on Jan 13, 2023 going ex on Dec 20, 2022
Dec 21, 2022
Jan 13, 2023
Dec 20, 2022
Aug 18, 2022
MDT.NB Final Cash Dividend of gross USD 0.68 paid on Oct 14, 2022 going ex on Sep 22, 2022
Sep 23, 2022
Oct 14, 2022
Sep 22, 2022
Ver más
División de acciones
Fecha
Tipo
Relación

No datos encontrados
Fecha
Tipo
Relación

No datos encontrados